Eng
Evaluation of the safety and efficacy of the application of cultured autologous and allogenic multipotent mesenchymal stromal cells in patients with neurocompression syndrome due to herniated nucleus pulposus.
Evaluation of the safety and efficacy of paravertebral introduction of cultured autologous and allogenic multipotent mesenchymal stromal cells from adipose tissue in patients with neurocompression syndrome due to herniated nucleus pulposus in the cervical and/or lumbar spine.
Product of cultured autologous and allogenic multipotent mesenchymal stromal cells from adipose tissue.
Up to 100 million cells
The use of MMSCs for patients with herniated nucleus pulposus is carried out by paravertebral introduction.